Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

ClinicalTrials.gov ID: NCT03919994

Public ClinicalTrials.gov record NCT03919994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OASIS: Observational Study of LAIs In Schizophrenia

Study identification

NCT ID
NCT03919994
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Alkermes, Inc.
Industry
Enrollment
338 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2019
Primary completion
Jan 3, 2023
Completion
Jan 3, 2023
Last update posted
Feb 1, 2023

2019 – 2023

United States locations

U.S. sites
57
U.S. states
23
U.S. cities
52
Facility City State ZIP Site status
Alkermes Investigational Site Tucson Arizona 85719
Alkermes Investigational Site Costa Mesa California 92626
Alkermes Investigational Site El Cajon California 92021
Alkermes Investigational Site Granada Hills California 91334
Alkermes Investigational Site Oceanside California 92054
Alkermes Investigational Site Panorama City California 91402
Alkermes Investigational Site San Bernardino California 92404
Alkermes Investigational Site Dayville Connecticut 06241
Alkermes Investigational Site Hialeah Florida 33012
Alkermes Investigational Site Hialeah Florida 33016
Alkermes Investigational Site Lauderdale Lakes Florida 33319
Alkermes Investigational Site Miami Florida 33136
Alkermes Investigational Site Miami Gardens Florida 33014
Alkermes Investigational Site Orlando Florida 32803
Alkermes Investigational Site Panama City Florida 32405
Alkermes Investigational Site Tallahassee Florida 32308
Alkermes Investigational Site Augusta Georgia 30912
Alkermes Investigational Site Lawrenceville Georgia 30046
Alkermes Investigational Site Honolulu Hawaii 96817
Alkermes Investigational Site Honolulu Hawaii 96826
Alkermes Investigational Site Schaumburg Illinois 60194
Alkermes Investigational Site Springfield Illinois 62702
Alkermes Investigational Site Indianapolis Indiana 46202
Alkermes Investigational Site Bel Air Maryland 21015
Alkermes Investigational Site Boston Massachusetts 02114
Alkermes Investigational Site Grand Rapids Michigan 49503
Alkermes Investigational Site Kalamazoo Michigan 49008
Alkermes Investigational Site Kansas City Missouri 64108
Alkermes Investigational Site Raymore Missouri 64083
Alkermes Investigational Site St Louis Missouri 63118
Alkermes Investigational Site St Louis Missouri 63128
Alkermes Investigational Site St Louis Missouri 63141
Alkermes Investigational Site Lincoln Nebraska 68526
Alkermes Investigational Site Manchester New Hampshire 03101
Alkermes Investigational Site Buffalo New York 14215
Alkermes Investigational Site Glen Oaks New York 11004
Alkermes Investigational Site Jamaica New York 11418
Alkermes Investigational Site New York New York 10032
Alkermes Investigational Site Poughkeepsie New York 12603
Alkermes Investigational Site Beachwood Ohio 44122
Alkermes Investigational Site Fairlawn Ohio 44333
Alkermes Investigational Site Westlake Ohio 44145
Alkermes Investigational Site Wooster Ohio 44691
Alkermes Investigational Site Durant Oklahoma 74701
Alkermes Investigational Site Tulsa Oklahoma 74114
Alkermes Investigational Site Tulsa Oklahoma 74136
Alkermes Investigational Site Eugene Oregon 97401
Alkermes Investigational Site Wyomissing Pennsylvania 19610
Alkermes Investigational Site Sioux Falls South Dakota 57104
Alkermes Investigational Site Franklin Tennessee 37067
Alkermes Investigational Site Austin Texas 78746
Alkermes Investigational Site Fort Worth Texas 76104
Alkermes Investigational Site Houston Texas 77074
Alkermes Investigational Site Richmond Texas 77407
Alkermes Investigational Site San Antonio Texas 78229
Alkermes Investigational Site Wichita Falls Texas 76306
Alkermes Investigational Site Salt Lake City Utah 84105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03919994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03919994 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →